Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
Neurobiology of Disease

Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease

Masashi Kitazawa, Salvatore Oddo, Tritia R. Yamasaki, Kim N. Green and Frank M. LaFerla
Journal of Neuroscience 28 September 2005, 25 (39) 8843-8853; DOI: https://doi.org/10.1523/JNEUROSCI.2868-05.2005
Masashi Kitazawa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Salvatore Oddo
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tritia R. Yamasaki
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kim N. Green
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Frank M. LaFerla
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

DOI 
https://doi.org/10.1523/JNEUROSCI.2868-05.2005
PubMed 
16192374
Published By 
Society for Neuroscience
History 
  • Received March 10, 2005
  • Revision received August 12, 2005
  • Accepted August 13, 2005
  • First published September 28, 2005.
  • Version of record published September 28, 2005.
Copyright & Usage 
Copyright © 2005 Society for Neuroscience 0270-6474/05/258843-11.00/0

Author Information

  1. Masashi Kitazawa,
  2. Salvatore Oddo,
  3. Tritia R. Yamasaki,
  4. Kim N. Green, and
  5. Frank M. LaFerla
  1. Laboratory of Molecular Neuropathogenesis, Department of Neurobiology and Behavior, University of California–Irvine, Irvine, California 92697-4545
View Full Text

Author contributions

Disclosures

    • Received March 10, 2005.
    • Revision received August 12, 2005.
    • Accepted August 13, 2005.
  • This work was supported by a grant from the Alzheimer's Association and by National Institutes of Health Grants AG17968 and AG0212982.

  • Correspondence should be addressed to Dr. Frank M. LaFerla, Department of Neurobiology and Behavior, 1109 Gillespie Neuroscience Facility, University of California–Irvine, Irvine, CA 92697-4545. E-mail: laferla{at}uci.edu.

  • DOI:10.1523/JNEUROSCI.2868-05.2005

  • Copyright © 2005 Society for Neuroscience 0270-6474/05/258843-11$15.00/0

Online Impact

 

Article usage

Select a custom date range for the past year
E.g., 2023-04-01
to
E.g., 2023-04-01

Article usage: January 2018 to March 2023

AbstractFullPdf
Jan 2018137155
Feb 2018386250
Mar 2018257749
Apr 2018235939
May 2018227759
Jun 2018265630
Jul 2018143317
Aug 201844613
Sep 2018135426
Oct 2018137028
Nov 2018116321
Dec 2018173927
Total 2018219707414
Jan 2019175528
Feb 2019103221
Mar 2019117244
Apr 2019327547
May 2019176839
Jun 2019184932
Jul 2019144238
Aug 2019118328
Oct 20192219837
Nov 201974920
Dec 2019156926
Total 2019174792360
Jan 2020185918
Feb 2020144614
Mar 202075922
May 2020145021
Jun 202083116
Jul 202094721
Aug 20206229
Sep 2020124322
Oct 2020126326
Nov 2020914427
Dec 2020275726
Total 2020136621222
Jan 2021164923
Feb 20211531241
Mar 2021124851
Apr 2021914441
May 2021215136
Jun 20211019237
Jul 202155935
Aug 202174817
Sep 2021125627
Oct 202156953
Nov 2021217044
Dec 2021126530
Total 20211451163435
Jan 202265637
Feb 2022125637
Mar 2022167836
Apr 2022126137
May 2022124637
Jun 2022115240
Jul 2022193211
Aug 202284414
Sep 2022284835
Oct 2022173521
Nov 20221110
Dec 202276614
Total 2022149585319
Jan 20233011842
Feb 2023139524
Mar 2023138743
Total 202356300109
Total87941681859
Back to top

In this issue

The Journal of Neuroscience: 25 (39)
Journal of Neuroscience
Vol. 25, Issue 39
28 Sep 2005
  • Table of Contents
  • About the Cover
  • Index by author
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease
Masashi Kitazawa, Salvatore Oddo, Tritia R. Yamasaki, Kim N. Green, Frank M. LaFerla
Journal of Neuroscience 28 September 2005, 25 (39) 8843-8853; DOI: 10.1523/JNEUROSCI.2868-05.2005

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
Lipopolysaccharide-Induced Inflammation Exacerbates Tau Pathology by a Cyclin-Dependent Kinase 5-Mediated Pathway in a Transgenic Model of Alzheimer's Disease
Masashi Kitazawa, Salvatore Oddo, Tritia R. Yamasaki, Kim N. Green, Frank M. LaFerla
Journal of Neuroscience 28 September 2005, 25 (39) 8843-8853; DOI: 10.1523/JNEUROSCI.2868-05.2005
Reddit logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Materials and Methods
    • Results
    • Discussion
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • M2 cortex circuitry and sensory-induced behavioral alterations in Huntington’s Disease: role of superior colliculus
  • Severely Attenuated Visual Feedback Processing in Children on the Autism Spectrum
  • Tip60's Novel RNA-Binding Function Modulates Alternative Splicing of Pre-mRNA Targets Implicated in Alzheimer's Disease
Show more Neurobiology of Disease
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.